ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

APH Alliance Pharma Plc

39.70
0.20 (0.51%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Alliance Pharma Plc LSE:APH London Ordinary Share GB0031030819 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.20 0.51% 39.70 39.50 39.70 39.75 38.10 39.05 1,198,676 16:29:46
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 167.42M 936k 0.0017 233.53 214.44M

Alliance Pharma PLC Total Voting Rights (7423A)

02/01/2018 2:00pm

UK Regulatory


Alliance Pharma (LSE:APH)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Alliance Pharma Charts.

TIDMAPH

RNS Number : 7423A

Alliance Pharma PLC

02 January 2018

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Total Voting Rights

Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, makes the following notification in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1.

As at 29 December 2017 the Company's issued share capital consists of 474,989,998 Ordinary Shares of 1p each.

The total number of voting rights in the Company is 474,989,998 and this figure may be used by shareholders as the denominator for the calculations by which they should determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information:

 
 Alliance Pharma plc                           + 44 (0) 1249 466966 
 John Dawson, Chief Executive 
  Officer 
  Peter Butterfield, Deputy 
  Chief Executive Officer 
  Andrew Franklin, Chief 
  Financial Officer 
 www.alliancepharma.co.uk 
 
   Buchanan                                   + 44 (0) 20 7466 5000 
 Mark Court / Sophie Cowles 
 
 Numis Securities Limited                     + 44 (0) 20 7260 1000 
 Nominated Adviser: Michael 
  Meade / Freddie Barnfield 
 Corporate Broking: James 
  Black / Toby Adcock 
 
 Investec Bank plc                             +44 (0) 20 7597 5970 
 Corporate Finance: Daniel 
  Adams / Ed Thomas 
  Corporate Broking: Patrick 
  Robb / Rob Baker 
 

Notes to editors:

About Alliance Pharma

Alliance, founded in 1998, is an international speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has sales in more than 100 countries worldwide via direct sales, joint ventures and a network of distributors. Alliance has a strong track record of acquiring the rights to established niche products and it currently owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The Company continues to explore opportunities to expand its product portfolio.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS

The company news service from the London Stock Exchange

END

TVRUGUCAGUPRGWP

(END) Dow Jones Newswires

January 02, 2018 09:00 ET (14:00 GMT)

1 Year Alliance Pharma Chart

1 Year Alliance Pharma Chart

1 Month Alliance Pharma Chart

1 Month Alliance Pharma Chart

Your Recent History

Delayed Upgrade Clock